OBJECTIVES The aim of this study was to develop a prediction model to identify patients with low-risk Staphylococcus aureus bacteremia (SAB), in whom infective endocarditis (IE) can be ruled out based on transthoracic echocardiogram (TTE).
S taphylococcus aureus is a major cause of bacteremia and commonly leads to severe complications (1-3). Infective endocarditis (IE) occurs in up to 25% of cases and is associated with lengthy hospitalization, relapsing bacteremia, and high mortality (3-9). Identification of IE is crucial because patients require a more complex approach to management, which includes prolonged use of intravenous antibiotic therapy (10, 11) . The majority of patients with IE do not have clinically evident disease at the time of bacteremia, which makes early diagnosis challenging (4, 8, 12) .
Current guidelines for management of S. aureus bacteremia (SAB) assume IE, requiring at least 4 weeks of intravenous antibiotic therapy unless a transesophageal echocardiogram (TEE) is negative (13) . This is based on historical studies demonstrating that transthoracic echocardiography (TTE) may not be sufficiently sensitive to rule out IE (4). However, performing a TEE on all patients is resource intensive, and clinicians frequently deviate from current guidelines according to TEE availability, patient refusal, and comorbid critical illness (8, 14, 15) .
Modern echocardiographic techniques and equipment have improved TTE sensitivity in SAB, particularly in low-risk patients (16) (17) (18) . TTE might therefore exclude IE in many patients and eliminate the need for more invasive testing with TEE (19) .
Thus, we sought to describe the current use of echocardiography in a multicenter SAB cohort in Toronto, Canada. We then tested the potential of a multivariable model to identify low-risk patients, in whom IE can be ruled out based on TTE alone.
METHODS
PATIENTS AND SETTING. We conducted our study at 7 university-affiliated and community hospitals in the Greater Toronto area. We included only adult inpatients (age $18 years) with a first SAB episode and excluded patients who died, were deemed suitable for palliative care only, were transferred to another facility, or left against medical advice within 48 h of bacteremia. We entered each patient in the study only once, using the first positive blood culture as the index isolate. Request 
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A U G U S T 2 0 1 5 : 9 2 4 -3 1 (16) 7 (26) 14 (16) Early infectious foci † Intravascular catheter 48 (18) 77 (17) 6 (22) 15 (17) Skin/soft tissue 61 (23) 92 (20) 3 (11) 18 (20) Bone or joint 27 (10) 80 (18) 3 (11) 21 (23) Respiratory 47 (18) 75 (17) 6 (22) 20 (22 In the validation cohort, we used significant predictors in the final multivariable regression model as a clinical prediction rule for endocarditis. In determining diagnostic properties, we used our clinical prediction rule as the test and endocarditis as the criterion standard. We calculated sensitivity, specificity, and predictive values with 95% confidence intervals (CIs) using the Wilson method. For likelihood ratios, we calculated the 95% CI according to the method described by Simel et al. (23) .
All reported CIs were 2-sided 95% intervals, and all tests were 2-sided with a p < 0.05 significance level.
All analyses were performed with R version 3.0.1 (R Foundation for Statistical Computing, Vienna, Austria).
RESULTS
We identified 1,134 consecutive inpatients with firstepisode SAB; 833 met inclusion criteria (Figure 1) .
Bacteremia was community acquired in 230 patients (27.6%), health care-associated in 307 patients (36.9%), and nosocomial in 281 patients (33.7%). Values are median (interquartile range) or n (%). *Location of acquisition was not available for 9 patients (1.7%). †Documented infectious foci within 10 days of SAB, excluding IE. Some patients had >1 infectious focus. Data were not available for 7 patients (1.3%). ‡Data were not available for 22 patients (4.1%). §Data were not available for 10 patients (1.9%).
MSSA ¼ methicillin-sensitive Staphylococcus aureus; other abbreviations as in Table 1 .
A U G U S T 2 0 1 5 : 9 2 4 -3 1 were at low risk in the validation cohort. Multivariable model criteria had a sensitivity of 97% for IE and a specificity of 52%. The negative predictive value for IE was 99%, and the positive predictive value was 25% (Table 4) 
DISCUSSION
We evaluated 833 consecutive inpatients with SAB who received echocardiography at 7 community and academic hospitals. Using a split derivation and validation cohort, we found that a normal TTE ruled out IE in patients without community-acquired SAB, high-risk cardiac conditions, and intravenous drug use. Our criteria were 97% sensitive for IE, with a negative predictive value of 99% in a population with 14.2% IE prevalence. Specificity was lower (52%), possibly because of the stringent requirements for a normal TTE. On the basis of our findings, we propose that our combined clinical and TTE criteria are sufficient to rule out IE in a sizeable proportion of patients with SAB. The use of this approach eliminated the need for a TEE in almost one-half of these patients (45%), while missing IE in only 0.4% of those screened.
Few studies using modern echocardiography have examined a model with clinical and TTE criteria (19) .
All were small or single-center studies, and none used separate derivation and validation cohorts (17, 18, 24) .
In a 2009 to 2010 study, Rasmussen et al. (17) concluded that TTE may be an adequate screening tool in patients at low risk for IE; however, criteria were complex and based on many variables, which introduces model instability. In another small study from 2006 to 2011, IE was rare in patients without prosthetic cardiac devices who had no valvular regurgitation on echocardiogram (24) . In an older single-center study, patients without prosthetic cardiac material, TTE evidence of regurgitation, and clinical embolic phenomena had a <2% post-test probability of IE (18) . Our study supports the role of TTE in risk stratification, although our clinical predictors and definition of normal TTE differed (18, 19, 24) .
In contrast to other recent studies of nosocomial SAB, we demonstrate that TTE combined with simple clinical risk criteria is useful to rule out IE in SAB acquired from any location. Although 5 high-risk criteria had >97% sensitivity and >99% negative predictive value for IE in nosocomial SAB (14) , diagnostic properties were less robust when these criteria were applied to a prospective cohort that also included community-acquired and health care-associated SAB (15) . Khatib and Sharma (15) found evidence of IE in only 0.4% of patients with uncomplicated SAB, defined on the basis of clinical criteria; however, the majority did not receive any form of cardiac imaging (14, 15) , and other studies with higher rates of echocardiography utilization do not support the use of clinical predictors alone to rule out IE (8, 12, 19) .
Our study has several strengths. We examined a large SAB cohort from 7 diverse hospital sites, whereas most studies are limited to single hospital centers (15, 18, 24) . Furthermore, all patients included in our multivariable model received at least 1 echocardiogram, in contrast to other large cohorts in which the majority did not receive cardiac imaging (9, 14 
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